These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8492755)

  • 21. Treatment for multisystem Langerhans' cell histiocytosis.
    Katz BZ
    J Pediatr; 2002 Feb; 140(2):280. PubMed ID: 11865293
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary pre-leukaemia and etoposide.
    Lancet; 1991 Nov; 338(8777):1269-70. PubMed ID: 1682661
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
    Yu LC; Shenoy S; Ward K; Warrier RP
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis.
    Helmbold P; Hegemann B; Holzhausen HJ; Klapperstück T; Marsch WC
    Arch Dermatol; 1998 Oct; 134(10):1275-8. PubMed ID: 9801684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
    Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
    Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
    Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
    J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The price of success.
    Grunberg SM; Burris H; Livingston R
    J Clin Oncol; 1995 Mar; 13(3):797-8. PubMed ID: 7884441
    [No Abstract]   [Full Text] [Related]  

  • 31. Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
    Kajita N; Saito Y; Makimoto A; Miyahara S; Yuza Y
    Pediatr Int; 2020 Jun; 62(6):742-744. PubMed ID: 32495974
    [No Abstract]   [Full Text] [Related]  

  • 32. Class I histiocytosis: response to combination of etoposide and prednisolone.
    Datta V; Mishra OP; Das BK; Kumar M; Bhargava V; Singla PN
    Indian Pediatr; 1999 Jan; 36(1):83-6. PubMed ID: 10709128
    [No Abstract]   [Full Text] [Related]  

  • 33. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K; Flaherty L; Varterasian M
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract]   [Full Text] [Related]  

  • 34. Langerhans cell histiocytosis.
    Chu T
    Australas J Dermatol; 2001 Nov; 42(4):237-42. PubMed ID: 11903153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute leukemia in association with Langerhans cell histiocytosis.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
    Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
    Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
    J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
    [No Abstract]   [Full Text] [Related]  

  • 37. Epipodophyllotoxins and secondary leukemia.
    Womer RB
    Pediatr Hematol Oncol; 1993; 10(2):xi-xiii. PubMed ID: 8318365
    [No Abstract]   [Full Text] [Related]  

  • 38. Epipodophyllotoxins and secondary leukaemia.
    Kumar L
    Lancet; 1993 Oct; 342(8875):819-20. PubMed ID: 8104269
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
    Nishimura S; Sato T; Ueda H; Ueda K
    J Clin Oncol; 2001 Nov; 19(21):4182-3. PubMed ID: 11689590
    [No Abstract]   [Full Text] [Related]  

  • 40. Commenting on "Vulvar langerhans cell histocytosis: a case report and review of the literature" by Santillan et al. 91:241-246.
    Powell JL; Otis CN
    Gynecol Oncol; 2004 Jun; 93(3):719; author reply 719. PubMed ID: 15196873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.